Related news for: immunotherapy
Dr Joshua Tobin a haematologist-in-training at Mater has been awarded the prestigious 2019 Celgene Future Leaders in Hematology Award in Orlando, Florida on Saturday 7 December.
Dr Josh Tobin receives 2019 Celgene Award
Mater Research CEO Professor Maher Gandhi has secured additional funding from the Leukaemia Foundation to investigate a new therapeutic approach for follicular lymphoma (FL).
Mater researcher investigates a new therapeutic approach for follicular lymphoma
Mater Research—University of Queensland (MRI—UQ) Acting Director Professor Maher Gandhi has been awarded $3.6 million to improve treatment for relapsed lymphoma patients.
$3.6 million awarded to develop treatment for relapsed lymphoma patients
Mater Research’s Cancer Immunotherapies Research Group have received prestigious travel awards to attend international conferences
Cancer Immunotherapies Research Group receive prestigious travel awards